Abstract
Certain classes of antibodies are capable of lysing tumor cells by either activating complement (complement-dependent cytotoxicity, or CDC) or by mediating immune effector cells (antibody-dependent cellular cytotoxicity, or ADCC). Non-cytotoxic antibodies are also capable of cell lysis after coupling with toxins, chemotherapeutic drugs, or radioisotopes. In addition, there are antibodies capable of blocking cell surface receptors, thereby inhibiting growth, metastasis, and invasion of the tumor cells. In view of these anti-tumor capabilities, a number of clinical trials involving monoclonal antibodies (Mab) targeted against human cancer have been performed. With the technical feasibility to produce large quantities of purified monoclonal antibodies with defined specificity, isotype, and function, monoclonal antibodies have generated much hope for the immunotherapy of human cancer.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abe, T., and Norton, W. T. (1974) J. Neurochem. 23, 1025–1036.
Ando, S. (1983) Neurochem. Internatl. 5, 507–537.
Ando, S., Yu, R. K., Scarsdale, J. N., Kusunoki, S., and Prestegard, J. H. (1989) J. Biol. Chem. 246, 3478–3483.
Anh-Tuan, N., Pick, J., Mod, A., and Hollan, S. R. (1986) Eur. J. Cancer Clin. Oncol. 22, 1003–1007.
Bajorin, D., Chapman, P., Kunicka, J., Cordon-Cardo, C., Wong, C., Oettegen, H. F., Old, L. J., Dantis, L., Templeton, M. A., and Houghton, A. N. (1988) Proc. Annu. Meet. Am. Soc. Clin. Oncol. 7, A967.
Bernhard, H., Meyer Zum Buschenfelde, K. H., and Dippold, W. G. (1989) Int. J. Cancer 44, 155–160.
Berra, B., Gaini, S. M., and Riboni, L. (1985) Int. J. Cancer 36, 363–366.
Berra, B., Riboni, L., DeGasperi, R., Gaini, S. M., and Ragnotti, G. (1983) J. Neurochem. 40, 777–782.
Bosslet, K., Mennel, H. D., Rodden, F., Bauer, B. L., Wagner, E., Altmannberger, A., Sedlacek, H., and Wiegandt, H. (1989) Cancer Immunol. Immunother. 29, 171–178.
Bouchon, B., Portoukalian, J., and Bornet, H. (1985) Biochem. Internatl. 10, 531–538.
Brodin, T., Hellström, I., Hellström, K. E., Karlsson, K. A., Sjogren, H. O., Stromberg, N., and Thurin, J. (1985) Biochem. Biophys. Acta. 827, 349–353.
Cahan, L. D., Irie, R. F., Singh, R., Cassidenti, A., and Paulson, J. C. (1982) Proc. Natl. Acad. Sci. USA 79, 7629–7633.
Carubia, J. M., Yu, R. K., Macala, L. J., Kirkwood, J. M., and Varga, J. M. (1984) Biochem. Biophys. Res. Commun. 120, 500–504.
Chapman, P. B., Lonberg, M., and Houghton, A. N. (1990) Cancer Res. 50, 1503–1509.
Cheresh, D. A., Honsik, C. J., Staffileno, L. K., Jung, G., and Reisfeld, R. A. (1985) Proc. Natl. Acad. Sci. USA 82, 5155–5159.
Cheresh, D. A., Vark, A. P., Varki, N. M., Stallcup, W. B., Levine, J., and Reisfeld, R. A. (1984) J. Biol. Chem. 259, 7453–7459.
Cheung, N. V., Lazarus, H., Miraldi, F. D., Abramowsky, C. R., Kallick, S., Saarinen, U. M., Spitzer, T., Strandojord, S. E., Coccia, P. F., and Berger, N. A. (1987) J. Clin. Oncol. 5, 1430–1440.
Cheung, N. V., Medof, M. E., and Munn, D. (1988) Adv. Neuroblastoma Res. 2, 619–632.
Cheung, N. V., and Miraldi, F. D. (1988) Adv. Neuroblastoma Res. 2, 595–604.
Constantine-Patton, M., Blum, A. S., Mendez-Otero, R., and Barnstable, C. J. (1986) Nature 324, 459–462.
Dippold, W. G., Diens, H. P., Knuth, A., and Buschenfelde, K. H. M. (1985) Cancer Res. 45, 3699–3705.
Dippold, W. G., Knuth, A., and Buschenfelde, K. H. (1984) Cancer Res. 44, 806–810.
Dippold, W. G., Lloyd, K. O., Li, L. T. C., Ikeda, H., Oettgen, H. F., and Old, L. J. (1980) Proc. Natl. Acad. Sci. USA 77, 6114–6118.
Dohi, T., Nores, G. A., Oguchi, H., Inutusa, H., and Hakomori, S. (1989) in Gangliosides and Cancer, (Oettgen, H. F., ed.) pp. 273–282, VCH Publishers, Weinheim, FRG.
Elder, D. E., Rodeck, U., Thurin, J., Cardillo, F., Clark, W. H., Stewart, R., and Herlyn, M. (1989) Cancer Res. 49, 5091–5096.
Etienne-Dercerf, J., Gosselin-Rey, C., Gosselin, L., and Winand, R. (1986) J. Endocrinol. Invest. 9, 57–63.
Fredman, P., von Hoist, H., Collins, V. P., Ammar, A., Dellheden, B., Wahren, B., Granholm, L., and Svennerholm, L. (1986) Neurol. Res. 8, 123–126.
Fukushi, Y., Kannagi, R., Hakomori, S., Shepard, T., Kulander, B. G., and Singer, J. W. (1985) Cancer Res. 45, 3711–3717.
Fukushi, Y., Nudelman, E., Levery, S. B., Rauvala, H., and Hakomori, S. (1984) J. Biol. Chem. 259, 10511–10517.
Furukawa, K., Yamaguchi, H., Oettgen, H. F., Old, J. L., and Lloyd, K. O. (1988) J. Biol. Chem. 34, 18507–18512.
Goff, B., Lee, W. M. F., Westerick, M. A., and Macher, B. A. (1983) Eur. J. Biochem. 130, 553–557.
Goodman, G. E., Hellström, I., Hummel, D., Brodzinsky, L., Yeh, M. Y., and Hellström, K. E. (1987) Proc. Am. Soc. Clin. Oncol. 6, A823.
Gross, N., Beck, D., Portoukalian, J., Favre, S., and Carrel, S. (1989) Int. J. Cancer 43, 665–671.
Hakomori, S., (1984) Ann. Rev. Immunol. 2, 103–126.
Hakomori, S. (1989) in Gangliosides and Cancer (Oettgen, H. F., ed.) pp. 57–68, VCH Publishers, Weinheim, FRG.
Hakomori, S. (1984) in Monoclonal Antibodies and Functional Cell Lines (Kenneth, R. H., Bechtol, K. B., McKearn, T. J., eds.) pp. 67–100, Plenum Press, New York.
Hamberger, A., and Svennerholm, L. (1971) J. Neurochem. 18, 1821–1829.
Hellström, I., Brankovan, V., and Hellström, K. E. (1985) Proc. Natl. Acad. Sci. USA 82, 1499–1502.
Higashi, H., Hirabayashi, Y., Hirota, M., Matsumoto, M., and Kato, S. (1987), Jpn. J. Cancer Res. 78, 1309–1313.
Hirabayashi, Y., Hamoka, A., Matsumoto, M., Matsubara, T., Tagawa, M., Wakabayashi, S., and Tanaguchi, T. (1985) J. Biol. Chem. 260, 13328–13333.
Hirabayashi, Y., Higashi, H., Kato, S., Taniguchi, M., and Matsumoto, M. (1987) Jpn. J. Cancer Res. 78, 614–620.
Hirabayashi, Y., Sugimoto, M., Ogawa, T., Matsumoto, M., Tagawa, M., and Taniguchi, T. (1986) Biochem. Biophys. Acta 875, 126–128.
Holm, M., Mansson, J. E., Vanier, M. T., and Svennerholm, L. (1972) Biochim. Biophys. Acta 280, 356–364.
Honsik, C. J., Jung, G., and Reisfeld, R. A. (1986) Proc. Natl. Acad. Sci. USA 83, 7892–7897.
Houghton, A. N., Mintzer, D., Cordon-Cardo, C., Welt, S., Fliegel, B., Vadhan, S., Carswell, E., Melamed, M. R., Oettegen, H. F., and Old, L. J. (1985) Proc. Natl. Acad. Sci. USA 82, 1242–1246.
Houghton, A. N., Yuasa, H., Chapman, P. B., and Wehe, K. (1989) in Gangliosides and Cancer (Oettgen, H. F., ed.) pp. 197–205, VCH Publishers, Weinheim, FRG.
Irie, R. F., Matsuki, T., and Morton, D. L. (1989) Lancet 786–787.
Irie, R. F., and Morton, D. L. (1986) Proc. Natl. Acad. Sci. USA 83, 8694–8698.
Irie, R. F., Sze, L. L., and Saxton, R. E. (1982) Proc. Natl. Acad. Sci. USA 79, 5666–5670.
Irie, R. F., Tai, T., and Morton, D. L. (1985) in Cancer Metastases, (Torisu, M., and Yoshida, T., eds.) pp. 371–384, Academic Press, New York.
Itonori, S., Hidari, K., Sanai, Y., Taniguchi, M., and Nagai, Y. (1989) Biochim. Biophys. Acta, in press.
Kannagi, R., Nudelman, E., and Hakomori, S. (1982) Proc. Natl. Acad. Sci. USA 79, 3470–3474.
Kyogashima, M., Killemura, T., and Taketomi, T. (1987) Jpn. J. Cancer Res. 78, 1229–1232.
Ladisch, S., Sweely, C. C., Becker, H., and Gage, D. (1989) J. Biol. Chem. 264, 12097–12105.
Ladisch, S., Wu, Z., Feig, S., Ulsh, L., Schwartz, E., Floutis, G., Wiley, F., Lenarsky, C., and Seeger, R. (1987) Int. J. Cancer 39, 73–76.
Lichtin, A. E., Gueery, D., Elder, D. E., Hamilton, R., LaRossa, D., Iliopoulos, D., Thurin, J., and Steplewski, Z. (1986) Proc. 8th Intl. Pigment Cell Conf., Tuscon, Arizona.
Liepkalns, V. A., Icard-Liepkalns, C., Yates, A. J., Thompson, D. K., and Hart, R. W. (1981) J. Neurochem. 36, 1959–1965.
Livingston, P. O. (1988) J. Cell. Biochem. 12E, 123.
Lonberg, M., Bajorin, D., Cheung, N. K., Cordon-Cardo, C., Dantis, L., Templeton, M. A., Oettgen, H. F., Old, L. J., and Houghton, A. N. (1988) Proc. Annu. Meet. Am. Soc. Clin. Oncol. 7, A668.
Magnani, J. L., Nilsson, B., Brockhouse, M., Zopor, D., Steplewski, Z., Koprowski, H., and Ginsberg, V. (1982) J. Biol. Chem. 157, 12752–12756.
Matsuki, T., Sze, L., Guiliano, A. E., and Irie, R. F. (1988) Proc. Annu. Mect. Am. Assoc. Cancer Res. 29, A1694.
Miyake, M., Ito, M., Ikeda, S., Hitomi, S., Taki, T., Kurata, M., Hino, A., Miyake, N., and Kannagi, R. (1988) Cancer Res. 48, 6154–6160.
Muchmore, E. A., Varki, N. M., Fukada, M., and Varki, A. (1987) FASEB J. 1, 229–235.
Mukhin, D., Prokazova, N. V., Bergelson, L. D., and Orekhov, A. N. (1989) Atherosclerosis 78, 39–45.
Natoli, E. J., Livingston, P. O., Cordon-Cardo, C., Pukel, C. S., Lloyd, K. O., Weigandt, H., Szalay, J., Oettgen, H. E., and Old, L. J. (1986) Cancer Res. 46, 4116–4120.
Nilsson, O., Mansson, J. E., Brezicka, T., Holmgren, J., Lindholm, L., Yngvason, F., Sorenson, L., and Svennerholm, L. (1984) Glycoconjugate J. 1, 43–49.
Nores, G. A., Dohi, T., Taniguchi, M., and Hakomori, S. (1987) J. Immunol. 139, 3171–3176.
Nudelman, E., Hakomori, S., Kannagi, R., Levery, S., Yeh, M., Hellström, K. E., and Hellström I. (1982) J. Biol. Chem. 257, 12752–12756.
Patel, K., Russell, R. J., Pemberton, L. F., Cheung, N. K., Walsh, F. S., Moore, S. E., Suginoto, T., and Kemshed, J. T. (1989) Br. J. Cancer 60, 861–866.
Portoukalian, J., Zwingelstein, G., Abdul-Malek, N., and Dore, J. F. (1978) Biochem. Biophys. Res. Commun. 85, 916–920.
Prokazova, N. V., Orekhov, N. A., Mukin, D. N., Mikhailenko, I. A., Kogtev, L. S., Sadovskaya, V. L., Golovanova, N. K., and Bergelson, L. D. (1987) Eur. J. Biochem. 167, 349–352.
Pukel, C., Lloyd, K. O., Travassos, L. R., Dippold, W. G., Oettgen, H. F., and Old, L. J. (1982) J. Exp. Med. 155, 1133–1147.
Rauvala, H. (1976) J. Biol. Chem. 251, 7517–7520.
Ravindranath, M. H., and Irie, R. H. (1988) in Malignant Melanoma: Biology, Diagnosis and Therapy (Nathanson, L., ed.) pp. 14–17, Kluwer Academic Publishers, Boston.
Ravindranath, M. H., Morton, D. L., and Irie, R. F. (1989) Cancer Res. 49, 3891–3897.
Ravindranath, M. H., Paulson, J. C., and Irie, R. F. (1988) J. Biol. Chem. 263, 2079–2086.
Ritter, G., Boosfeld, E., Markstein, E., Yu, R. K., Ren, S., Stallcup, W. B., Oettgen, H. F., Old, L. J., and Livingston, P. O. (1990) Cancer Res. 50, 1403–1410.
Ritter, G., Livirgston, P. O., Boosfeld, E., Weigandt, H., Yu, R. K., Oettgen, H. F., and Old, L. J. (1989) in Gangliosides and Cancer, (Oettgen, H. F., ed.) pp. 301–314, VCH Publishers, New York.
Sanai, Y., Yamaski, M., and Nagai, Y. (1989) Biochim. Biophys. Acta 958, 368–374.
Schibechi, S., Hersy, P., and Cheresh, D. (1989) Cancer Immunol. Immunother. 29, 109–117.
Schriever, F., Dennis, R. D., Pallman, B., Riethmuller, G., and Johnson, J. P. (1989) Hybridoma 8, 153–159.
Schulz, G., Cheresk, D. A., Varki, N. M., Yu, A., Skaffilerro, L. K. and Reisfeld, R. A. (1984) Cancer Res. 44, 5914–5920.
Sela, B.-A., Iliopoulos, D., Guerry, D., Herlyn, D., and Koprowski, H. (1989) J. Natl. Cancer Inst. 81, 1489–1492.
Senn, H. J., Orth, M., Fitze, E., Wieland, H., and Gerock, W. (1989) Eur. J. Biochem. 181, 657–662.
Shaponshnikova, G., Prokazova, N. V., Buznikov, G. A., Zvezdina, N. D., Teplitz, N. A., and Bergelson, L. D. (1984) Eur. J. Biochem. 140, 567–570.
Siddiqui, B., Beuhler, J., DeGregorio, M. W., and Macher, B. A. (1984) Cancer Res. 44, 5262–5265.
Svennerholm, L. (1963) J. Neurochem. 10, 613–623.
Tai, T., Cahan, L. D., Tsuchida, T., Morton, D. L., and Irie, R. F. (1985) Int. J. Cancer 35, 607–612.
Tai, T., Kawashima, I., Furukawa, K., and Lloyd, K. O. (1988a) Arch. Biochem. Biophys. 260, 51–55.
Tai, T., Kawashima, I., Tada, N., and Dairiki, K. (1988b) J. Biochem. 103, 682–687.
Tai, T., Kawashima, I., Tada, N., and Ikegami, S. (1988c) Biochim. Biophys. Acta 958, 134–138.
Tai, T., Paulson, J. C., Cahan, L. D., and Irie, R. F. (1983) Proc. Natl. Acad. Sci. USA 80, 5392–5396.
Tai, T., Sze, L. L., Kawashima, I., Saxton, R. E., and Irie, R. F. (1987) J. Biol. Chem. 262, 6803–6807.
Takamizawa, K., Iwamori, M., Mutai, M., and Nagai, Y. (1986) Biochim. Biophys. Acta 879, 73–77.
Thurin, J., Herlyn, M., Hindsgaul, O., Stromber, N., Karlsson, K. A., Elder, D., Stepleski, Z., and Koprowski, H. (1985) J. Biol. Chem. 260, 14556–14563.
Traylor, T. D., and Hogan, E. L. (1980) J. Neurochem. 34, 126–131.
Tsuchida, T., Otsuka, H., Niimura, M., Inoue, Y., Kukita, A., Hashimoto, Y., Seyama, Y., and Yamakawa, T. (1984) J. Dermatol. 11, 129–138.
Tsuchida, T., Saxton, R. E., Morton, D. L., and Irie, R. F. (1987) J. Natl. Cancer Inst. 78, 45–54.
Vadhan-Raj, S., Cordon-Cardo, C., Cars well, E., Mintzer, D., Dantis, L., Duteau, C., Templeton, M. A., Oettgen, H. F., Old, L. J., and Houghton, A. N. (1988) J. Clin. Oncol. 6, 1636–1648.
Vrionis, F., Wilkstrand, C. J., Predman, P., Mansson, O-E., Svennerholm, L., and Bigner, D. D. (1989) Cancer Res. 49, 6645–6651.
Welt, S., Carswell, E. A., Vogel, C. W., Oettgen, H. F., and Old, L. J. (1987) Clin. Immunol. Immunopathol 45, 214–229.
Weigandt, H. (1989) in Gangliosides and Cancer (Oettgen, H. P., ed.) pp. 5–15, VCH Publishers, Weinheim, PRG.
Weigandt, H. (1985) Glycolipids, p. 314, Elsevier, Amsterdam.
Westrick, M. A., Lee, W. M. P., Goff, B., and Macher, B. A. (1983a) Biochim. Biophys. Acta 750, 141–148.
Westrick, M. A., Lee, W. M. F., and Macher, B. A. (1983b) Cancer Res. 43, 5890–5894.
Yamaguchi, H., Furukawa, K., Fortunato, S. R., Livingston, P. O., Lloyd, K. O., Oettgen, H. P., and Old, L. J. (1987) Proc. Natl. Acad. Sci. USA 84, 2416–2420.
Yeh, M. Y., Hellström, I., Abe, K., Hakomori, S., and Hellström, K. E. (1982) Int. J. Cancer 29, 269–275.
Young, W. W., Jr., Durdik, J. M., Urdal, D., Hakomori, S., and Henny, C. S. (1981) J. Immunol. 126, 1–6.
Editor information
Copyright information
© 1990 Stockton Press
About this chapter
Cite this chapter
Irie, R.F., Ravindranath, M.H. (1990). Gangliosides as Targets for Monoclonal Antibody Therapy of Cancer. In: Borrebaeck, C.A.K., Larrick, J.W. (eds) Therapeutic Monoclonal Antibodies. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-11894-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-349-11894-6_5
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-11896-0
Online ISBN: 978-1-349-11894-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)